Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen Reid

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Journal of Thoracic Disease|July 8, 2015
MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targetsGlen Reid
Targeted Oncology|February 1, 2017
Exploiting microRNAs As Cancer TherapeuticsTamsin Robb, Glen Reid, Cherie Blenkiron
Advanced Drug Delivery Reviews|October 31, 2002
Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5Masashi Adachi, Glen Reid, John D Schuetz
Biophysical Reviews|January 13, 2018
Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancerTamkin Ahmadzada, Glen Reid, David R McKenzie
Expert Review of Anticancer Therapy|April 1, 2020
Asbestos-related cancers: the 'Hidden Killer' remains a global threatNico van Zandwijk, Glen Reid, Arthur L Frank
Frontiers in Genetics|April 30, 2013
Cell-free microRNAs: potential biomarkers in need of standardized reportingMichaela B Kirschner, Nico van Zandwijk, Glen Reid
Frontiers in Oncology|March 3, 2020
Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and FutureGlen Reid, Thomas G Johnson, Nico van Zandwijk
Critical Reviews in Oncology/Hematology|December 15, 2010
Circulating microRNAs: Association with disease and potential use as biomarkersGlen Reid, Michaela B Kirschner, Nico van Zandwijk
Plos One|March 6, 2014
Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5Ngan Ching Cheng, Nico van Zandwijk, Glen Reid
Frontiers in Physiology|October 7, 2022
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney diseaseQi Zheng, Glen Reid, Michael R Eccles, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Disease|July 8, 2015
MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targetsGlen Reid
Targeted Oncology|February 1, 2017
Exploiting microRNAs As Cancer TherapeuticsTamsin Robb, Glen Reid, Cherie Blenkiron
Advanced Drug Delivery Reviews|October 31, 2002
Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5Masashi Adachi, Glen Reid, John D Schuetz
Biophysical Reviews|January 13, 2018
Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancerTamkin Ahmadzada, Glen Reid, David R McKenzie
Expert Review of Anticancer Therapy|April 1, 2020
Asbestos-related cancers: the 'Hidden Killer' remains a global threatNico van Zandwijk, Glen Reid, Arthur L Frank
Frontiers in Genetics|April 30, 2013
Cell-free microRNAs: potential biomarkers in need of standardized reportingMichaela B Kirschner, Nico van Zandwijk, Glen Reid
Frontiers in Oncology|March 3, 2020
Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and FutureGlen Reid, Thomas G Johnson, Nico van Zandwijk
Critical Reviews in Oncology/Hematology|December 15, 2010
Circulating microRNAs: Association with disease and potential use as biomarkersGlen Reid, Michaela B Kirschner, Nico van Zandwijk
Plos One|March 6, 2014
Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5Ngan Ching Cheng, Nico van Zandwijk, Glen Reid
Frontiers in Physiology|October 7, 2022
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney diseaseQi Zheng, Glen Reid, Michael R Eccles, et al.
Pageof 9